tickrz reports
Alexion Pharmaceuticals Inc (ALXN)
Healthcare | Drugs
122.71  0.19%
ALXN vs DRUGS SECTOR & S&P 500
VALUATION
ALXNSECTORS&P 500
P/E RATIO54.5640.521.12
EV/EBITDA RATIO27.79133.412.66
P/S RATIO7.956.52.25
P/B RATIO3.097.73.45
QUALITY
RETURN ON EQUITY5.8%15.79%13.64%
RETURN ON CAPITAL5.42%19.38%10.09%
NET MARGIN13.25%14.46%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATION/A
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
6 OUT OF 9
DEBT-TO-EQUITY36%
INTEREST COVERAGE9x
CURRENT RATIO2.97
GROWTH
5 YR EPS GROWTH14.1%
5 YR SPS GROWTH30.68%
5 YR BPS GROWTH44.71%
Alexion Pharmaceuticals Inc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership